Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report)’s share price fell 7.4% on Tuesday . The company traded as low as $0.20 and last traded at $0.25. 18,561 shares were traded during mid-day trading, an increase of 265% from the average session volume of 5,087 shares. The stock had previously closed at $0.27.
Guided Therapeutics Trading Down 7.4%
The company’s fifty day moving average is $0.24 and its 200-day moving average is $0.24. The firm has a market capitalization of $21.49 million, a P/E ratio of -5.00 and a beta of 0.64.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last announced its earnings results on Thursday, November 13th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.06 million for the quarter.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Featured Stories
- Five stocks we like better than Guided Therapeutics
- How to Buy Gold Stock and Invest in Gold
- Why Taiwan Semiconductor’s 6.5% Dip Could Be a Smart Buy
- Find and Profitably Trade Stocks at 52-Week Lows
- RTX Surges to Record Highs as Defense Orders Explode
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Smart Money Is Buying Auto Suppliers, Not Car Brands
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
